Koyfin Home > Directory > Health Care > Amicus Therapeutics > Long-term Debt / Equity

Amicus Therapeutics Long-term Debt / Equity Chart (FOLD)

Amicus Therapeutics annual/quarterly Long-term Debt / Equity from 2006 to 2018.
  • Amicus Therapeutics Long-term Debt / Equity for the quarter ending December 12, 2018 was $94m a 65.92% increase of 62m year over year
  • Amicus Therapeutics Long-term Debt / Equity for the last 12 months ending December 12, 2018 was $94m a 65.92% increase of 62m year over year
  • Amicus Therapeutics Annual Long-term Debt / Equity for 2018 was $94m a 50.41% increase of 47m from 2017
  • Amicus Therapeutics Annual Long-term Debt / Equity for 2017 was $47m a 7.82% increase of 4m from 2016
  • Amicus Therapeutics Annual Long-term Debt / Equity for 2016 was $43m a 72.11% increase of 31m from 2015
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
View Chart On Koyfin

Quarterly FOLD Long-term Debt / Equity Data

12/2018$94m
09/2018$78m
06/2018$30m
03/2018$32m
12/2017$47m
09/2017$39m
06/2017$60m
03/2017$50m
12/2016$43m
09/2016$20m

Annual FOLD Long-term Debt / Equity Data

2018$94m
2017$47m
2016$43m
2015$12m
2014$9m
2013$31m
2012$0m
2010$2m
2009$3m
2008$0m